ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 144 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,702,115 | +1439.7% | 320,549 | +2663.4% | 0.00% | – |
| Q2 2023 | $110,548 | +1024.1% | 11,600 | -98.3% | 0.00% | -100.0% |
| Q4 2022 | $9,834 | -99.4% | 664,447 | +673.5% | 0.01% | +400.0% |
| Q3 2022 | $1,641,000 | -14.9% | 85,897 | -14.2% | 0.00% | 0.0% |
| Q1 2022 | $1,928,000 | +163.7% | 100,126 | +227.0% | 0.00% | – |
| Q3 2021 | $731,000 | +67.3% | 30,618 | +102.9% | 0.00% | – |
| Q1 2021 | $437,000 | -90.3% | 15,093 | -90.6% | 0.00% | -100.0% |
| Q4 2020 | $4,503,000 | +401.4% | 160,094 | +422.5% | 0.00% | +200.0% |
| Q3 2020 | $898,000 | +14.5% | 30,642 | +18.1% | 0.00% | 0.0% |
| Q2 2020 | $784,000 | +121.5% | 25,939 | +118.3% | 0.00% | 0.0% |
| Q1 2020 | $354,000 | – | 11,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $314,175,000 | 35.62% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $118,583,000 | 20.06% |
| Omega Fund Management, LLC | 844,680 | $25,171,000 | 10.42% |
| Vivo Capital, LLC | 1,686,527 | $50,259,000 | 4.55% |
| Orbimed Advisors | 4,673,850 | $139,281,000 | 2.34% |
| RA Capital Management | 1,165,184 | $34,722,000 | 1.10% |
| Polar Capital LLP | 375,000 | $11,175,000 | 0.12% |
| CAAS CAPITAL MANAGEMENT LP | 22,413 | $668,000 | 0.07% |
| FMR LLC | 5,713,343 | $170,258,000 | 0.02% |
| Laurion Capital Management LP | 50,000 | $1,490,000 | 0.02% |